Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy
Clinical trial NCT05519397 · COMPLETED
Trial details
- NCT number
- NCT05519397
- Sponsor
- Istanbul Training and Research Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-01
- Primary completion
- 2022-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.